Stalicla
ID: 6959089Stalicla is a drug development platform for neurodevelopmental disorders founded in 2017 by Lynn Durham.
3
Funding Rounds
$27.5m
Money raised
Recent Funding Rounds
Overview
Stalicla is a drug development platform for neurodevelopmental disorders founded in 2017 by Lynn Durham.
- Website:
- Business model: B2B
- Headquarters: Geneva
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ly** Du**** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Stalicla has raised a total of $27.47m in funding over 3 rounds.
Key Insights:
- Stalicla Venture Round, June 2025: $2.5m
- Stalicla January 2024 Series B Funding Round: $14m
- Stalicla Series A round, January 2019: $10.97m
Industries
Stalicla is active in the following industries: